🇪🇺 Sustiva in European Union

EMA authorised Sustiva on 28 May 1999

Marketing authorisation

EMA — authorised 28 May 1999

  • Marketing authorisation holder: Bristol-Myers Squibb Pharma EEIG
  • Status: approved

Sustiva in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Sustiva approved in European Union?

Yes. EMA authorised it on 28 May 1999.

Who is the marketing authorisation holder for Sustiva in European Union?

Bristol-Myers Squibb Pharma EEIG holds the EU marketing authorisation.